Boussard & Gavaudan Investment Management »

Zura Bio shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Zura Bio (ZURAW) shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $61k 188k 0.33
2023-06-30 $67k 188k 0.36
2023-03-31 $47k 188k 0.25

More positions owned by Boussard & Gavaudan Investment Management

Activision Blizzard
Horizon Therapeutics Pub L SHS
Chart Inds Note 1.000%11/1
Vmware Cl A Com
Seagen
Cnx Res Corp Note 2.250% 5/0
Booking Holdings Note 0.750% 5/0
Altair Engr Note 0.250% 6/0
Permian Resources Corp Note 3.250% 4/0
On Semiconductor Corp Note 5/0
Westrock (WRK)
Bgc Group Cl A (BGC)
Ambac Finl Group Com New (AMBC)
Cinemark Hldgs Note 4.500% 8/1
Dynavax Technologies Corp Note 2.500% 5/1

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Zura Bio

Highbridge Capital Management
Hudson Bay Capital Management
Polar Securities
Kim
Angelo, Gordon & Co
Whitebox Advisors
Millennium Management
Walleye Trading Advisors
Walleye Trading
CNH Partners
Warberg Asset Management
Deutsche Bank Aktiengesellschaft
Two Sigma Investments
Wolverine Asset Management

View all funds holding Zura Bio